News

ASCO News: Weekly Chemo Improves Quality of Life

ASCO News: Weekly Chemo Improves Quality of Life

June 5, 2013

In research presented at the American Society of Clinical Oncology meeting this week, researchers found that shortening the break between chemotherapy sessions improved quality of life for patients, without negatively impacting efficacy. Results from a randomized, phase III trial of over 800 women conducted in Italy showed that lower-dose weekly carboplatin plus paclitaxel was associated … Continued

Research

ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse

ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse

June 5, 2013

Research presented at the American Society of Clinical Oncology annual meeting this week suggests that adding the drug pazopanib (trade name Votrient) to standard treatment extends progression-free survival in ovarian cancer patients by 5.6 months. Pazopanib is an oral anti-angiogenesis drug already approved to treat kidney cancer.  The phase III study of over 900 women  … Continued

Research

Partner Member Profile: Nine Girls Ask

Partner Member Profile: Nine Girls Ask

May 23, 2013

Like many women with ovarian cancer, Joan Wyllie was misdiagnosed by multiple doctors before learning she had stage IV ovarian cancer. Once she learned what was causing her symptoms, Joan recalls, “For some reason, I was not one bit afraid. I knew I would be doing something [to help women with ovarian cancer] but I … Continued

Community

Ovarian Cancer Incidence Fell Along with Hormone Therapy Use

Ovarian Cancer Incidence Fell Along with Hormone Therapy Use

May 21, 2013

In a study published online in the Journal of Clinical Oncology on May 6, 2013, researchers reported results of a study investigating menopausal hormonal therapy (MHT) use and the incidence of ovarian cancer.  When a report from the Women’s Health Initiative linked breast cancer incidence to the use of menopausal hormonal therapy in 2002, there … Continued

Research

Decreases in Ovarian Cancer Correlate to Decrease in Use of...

Decreases in Ovarian Cancer Correlate to Decrease in Use of Hormone Replacement Therapy

May 16, 2013

A new study shows that rates of ovarian cancer decreased around the same time that the use of hormone replacement therapy dropped off. Overall, for women over 50, rates decreased by 21 percent from 1995 to 2008, from 38 cases out of 100,000 women to 30 out of 100,000. However, the author cautions that this … Continued

Research

Alliance Responds to Angelina Jolie's BRCA1 Announcement

Alliance Responds to Angelina Jolie's BRCA1 Announcement

May 15, 2013

Actress Angelina Jolie recently announced that she carries a mutation in the BRCA1 gene, which makes her more likely to develop breast and ovarian cancer. In the wake of that news, many media outlets reached out to the Ovarian Cancer National Alliance for commentary and perspective. Our CEO, Calaneet Balas, wrote a letter to the … Continued

Community

LifeIce: A Daughter's Gift of Love Becomes a Mother�...

LifeIce: A Daughter's Gift of Love Becomes a Mother's Legacy

May 9, 2013

How a daughter's homemade nutritional ice chips for her mother became LifeIce.

Community

"What Makes My Mother Special" Mother’s Day...

"What Makes My Mother Special" Mother’s Day Campaign

May 8, 2013

From May 1st until Mother's Day on May 12th, we'll honor special mothers on our website and Facebook.

Community

Update on Treatment for Recurrent Ovarian Cancer

Update on Treatment for Recurrent Ovarian Cancer

May 3, 2013

A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of therapy. Read the full article here

Research

Large Study Points to Similarities Between Endometrial and ...

Large Study Points to Similarities Between Endometrial and Ovarian Cancers

May 2, 2013

According to a large new study published May 2, 2013 in the prestigious journal Nature, researchers have found that endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup, and may respond to targeted drugs already being tested in clinical trials.  Furthermore, they found that genomic alterations in uterine serous tumors—the … Continued

Research

Experts Tackle Key Issues for Ovarian Cancer in New White P...

Experts Tackle Key Issues for Ovarian Cancer in New White Paper

May 1, 2013

Last fall, the Alliance convened a ground-breaking meeting in Washington, DC, to consider some of the most challenging topics facing the ovarian cancer community. A group of researchers, oncologists, regulatory experts, advocates and industry representatives attempted to answer questions such as: “How can more women be treated where they live?” “How can we facilitate increased … Continued

Advocacy

Partner Member Profile: Dancing For A Cure

Partner Member Profile: Dancing For A Cure

May 1, 2013

Susan Friedman was inspired to start Dancing For A Cure when her best friend of 40 years, Karen Schek, was diagnosed with ovarian cancer in 2006. “I really wasn’t sure what to do,” recalls Susan. “I owned a dance studio at the time, so I put up a notice on the bulletin board asking if … Continued

Community